Design, synthesis, and pharmacological evaluation of a novel series of pyridopyrazine-1,6-dione γ-secretase modulators.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of Medicinal Chemistry

• Publication date

  2014-01-28

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/jm401782hPMID 24428186
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• HIV-1 Integrase Inhibitors to Treat AIDS

  2015cited by this paper
• Synthesis of pyridopyrazine-1,6-diones from 6-hydroxypicolinic acids via a one-pot coupling/cyclization reaction.

  2013cited by this paper
• Development and mechanism of γ-secretase modulators for Alzheimer's disease.

  2013cited by this paper
• Design and synthesis of bicyclic heterocycles as potent γ-secretase modulators.

  2013cited by this paper
• Discovery of 2-methylpyridine-based biaryl amides as γ-secretase modulators for the treatment of Alzheimer's disease.

  2013cited by this paper
• Novel γ-secretase modulators for the treatment of Alzheimer's disease: a review focusing on patents from 2010 to 2012

  2013cited by this paper
• γ-Secretase Modulator (GSM) Photoaffinity Probes Reveal Distinct Allosteric Binding Sites on Presenilin*

  2013cited by this paper
• 2013 Alzheimer's disease facts and figures

  2013cited by this paper
• Presenilin Is the Molecular Target of Acidic γ-Secretase Modulators in Living Cells

  2012cited by this paper
• Presenilins and γ-secretase: structure, function, and role in Alzheimer Disease.

  2012cited by this paper
• First and Second Generation γ-Secretase Modulators (GSMs) Modulate Amyloid-β (Aβ) Peptide Production through Different Mechanisms

  2012cited by this paper
• Safety and tolerability of the γ-secretase inhibitor avagacestat in a phase 2 study of mild to moderate Alzheimer disease.

  2012cited by this paper
• γ-Secretase Modulators: Can We Combine Potency with Safety?

  2012cited by this paper
• Differential Effects between γ-Secretase Inhibitors and Modulators on Cognitive Function in Amyloid Precursor Protein-Transgenic and Nontransgenic Mice

  2012cited by this paper
• Effects of Single Doses of Avagacestat (BMS-708163) on Cerebrospinal Fluid Aβ Levels in Healthy Young Men

  2012cited by this paper
• Cyclic hydroxyamidines as amide isosteres: discovery of oxadiazolines and oxadiazines as potent and highly efficacious γ-secretase modulators in vivo.

  2012cited by this paper
• Design and synthesis of dihydrobenzofuran amides as orally bioavailable, centrally active γ-secretase modulators.

  2012cited by this paper
• Tandem photoaffinity labeling-bioorthogonal conjugation in medicinal chemistry.

  2012cited by this paper
• Design and synthesis of a novel series of bicyclic heterocycles as potent γ-secretase modulators.

  2012cited by this paper
• Development of clickable active site-directed photoaffinity probes for γ-secretase.

  2012cited by this paper
• The genetics of Alzheimer's disease.

  2012cited by this paper
• Piperidine acetic acid based γ-secretase modulators directly bind to Presenilin-1.

  2011cited by this paper
• γ-Secretase modulators as potential disease modifying anti-Alzheimer's drugs.

  2011cited by this paper
• Metabolism-directed design of oxetane-containing arylsulfonamide derivatives as γ-secretase inhibitors.

  2011cited by this paper
• Novel γ-secretase modulators: a review of patents from 2008 to 2010

  2011cited by this paper
• The Many Substrates of Presenilin/γ-Secretase

  2011cited by this paper
• Therapeutic intervention for Alzheimer's disease with γ-secretase inhibitors: still a viable option?

  2011cited by this paper
• The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics

  2011cited by this paper
• Targets for AD treatment: conflicting messages from γ‐secretase inhibitors

  2011cited by this paper
• Phenylpiperidine‐type γ‐secretase modulators target the transmembrane domain 1 of presenilin 1

  2011cited by this paper
• Novel γ-Secretase Enzyme Modulators Directly Target Presenilin Protein*

  2011cited by this paper
• A comprehensive non-clinical evaluation of the CNS penetration potential of antimuscarinic agents for the treatment of overactive bladder.

  2011cited by this paper
• What the halted phase III γ‐secretase inhibitor trial may (or may not) be telling us

  2011cited by this paper
• Target of γ‐secretase modulators, presenilin marks the spot

  2011cited by this paper
• Acute Effect on the Aβ Isoform Pattern in CSF in Response to γ-Secretase Modulator and Inhibitor Treatment in Dogs

  2010cited by this paper
• Defining desirable central nervous system drug space through the alignment of molecular properties, in vitro ADME, and safety attributes.

  2010cited by this paper
• Moving beyond rules: the development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties.

  2010cited by this paper
• P1‐236: E2012: A novel gamma‐secretase modulator‐pharmacology part

  2010cited by this paper
• The secretases: enzymes with therapeutic potential in Alzheimer disease

  2010cited by this paper
• Effect of tarenflurbil on cognitive decline and activities of daily living in patients with mild Alzheimer disease: a randomized controlled trial.

  2009cited by this paper
• Rapid assessment of a novel series of selective CB(2) agonists using parallel synthesis protocols: A Lipophilic Efficiency (LipE) analysis.

  2009cited by this paper
• Biotransformation of Xenobiotics

  2009cited by this paper
• A γ‐secretase inhibitor decreases amyloid‐β production in the central nervous system

  2009cited by this paper
• Modulation of the Partition Coefficient between Octanol and Buffer at pH 7.4 and pKa to Achieve the Optimum Balance of Blood Clearance and Volume of Distribution for a Series of Tetrahydropyran Histamine Type 3 Receptor Antagonists

  2009cited by this paper
• Physiochemical drug properties associated with in vivo toxicological outcomes.

  2008cited by this paper
• 2008 Alzheimer's disease facts and figures

  2008cited by this paper
• In Vitro P-glycoprotein Assays to Predict the in Vivo Interactions of P-glycoprotein with Drugs in the Central Nervous System

  2008cited by this paper
• Generation of Aβ38 and Aβ42 Is Independently and Differentially Affected by Familial Alzheimer Disease-associated Presenilin Mutations and γ-Secretase Modulation*

  2008cited by this paper
• Generation of Abeta38 and Abeta42 is independently and differentially affected by familial Alzheimer disease-associated presenilin mutations and gamma-secretase modulation.

  2008cited by this paper
• Dihydroxypyridopyrazine-1,6-dione HIV-1 integrase inhibitors.

  2007cited by this paper
• The influence of drug-like concepts on decision-making in medicinal chemistry

  2007cited by this paper
• Aβ Oligomers – a decade of discovery

  2007cited by this paper
• A UNIFIED MODEL FOR PREDICTING HUMAN HEPATIC, METABOLIC CLEARANCE FROM IN VITRO INTRINSIC CLEARANCE DATA IN HEPATOCYTES AND MICROSOMES

  2005cited by this paper
• Asymmetric synthesis of isoquinoline alkaloids.

  2004cited by this paper
• Evidence that nonsteroidal anti-inflammatory drugs decrease amyloid beta 42 production by direct modulation of gamma-secretase activity.

  2003cited by this paper
• NSAIDs and enantiomers of flurbiprofen target γ-secretase and lower Aβ42 in vivo

  2003cited by this paper
• Evidence That Nonsteroidal Anti-inflammatory Drugs Decrease Amyloid β42 Production by Direct Modulation of γ-Secretase Activity*

  2003cited by this paper
• NSAIDs and enantiomers of flurbiprofen target gamma-secretase and lower Abeta 42 in vivo.

  2003cited by this paper
• Aβ42-lowering Nonsteroidal Anti-inflammatory Drugs Preserve Intramembrane Cleavage of the Amyloid Precursor Protein (APP) and ErbB-4 Receptor and Signaling through the APP Intracellular Domain*

  2003cited by this paper
• A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity

  2001cited by this paper
• The genetics of Alzheimer's disease

  2000cited by this paper
• Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: An examination of in vitro half-life approach and nonspecific binding to microsomes.

  1999cited by this paper
• An efficient synthesis of substituted isoquinolines

  1983cited by this paper
• A synthesis of pyrido[1,2-a]quinoxalines and pyrido[1,2-a]-pyrazines

  1983cited by this paper
• Biotransformation of xenobiotics in the fetus.

  1980cited by this paper

• Pseudonatural Products for Chemical Biology and Drug Discovery

  2025cites this paper
• Discovery of Clinical Candidate PF-06648671: A Potent γ-Secretase Modulator for the Treatment of Alzheimer's Disease.

  2024cites this paper
• Characterizing the Chemical Space of γ-Secretase Inhibitors and Modulators.

  2021cites this paper
• Recent developments of small molecule γ-secretase modulators for Alzheimer's disease.

  2020cites this paper
• Computational prediction and molecular mechanism of γ-secretase modulators.

  2020cites this paper
• A concise and unexpected one-pot methodology for the synthesis of pyrazinone-fused pyridones

  2020cites this paper
• Generation of Leads for γ-Secretase Modulation.

  2020cites this paper
• Multidisciplinary approaches for targeting the secretase protein family as a therapeutic route for Alzheimer's disease

  2019cites this paper
• Isoquinoline-based biaryls as a robust scaffold for microtubule inhibitors.

  2019cites this paper
• The Use of Conformational Restriction in Medicinal Chemistry.

  2019cites this paper
• Challenges in the treatment of Alzheimer’s disease: recent progress and treatment strategies of pharmaceuticals targeting notable pathological factors

  2019cites this paper
• Discovery of tetrahydroindazoles as a novel class of potent and in vivo efficacious gamma secretase modulators.

  2018cites this paper
• The Curtius Rearrangement: Applications in Modern Drug Discovery and Medicinal Chemistry

  2018cites this paper
• Alzheimer’s Disease II

  2017cites this paper
• Protocol for the Direct Conversion of Lactones to Lactams Mediated by 1,5,7-Triazabicyclo[4.4.0]dec-5-ene: Synthesis of Pyridopyrazine-1,6-diones.

  2017cites this paper
• Trifluoromethyl Oxetanes: Synthesis and Evaluation as a tert‐Butyl Isostere

  2017cites this paper
• Structural and Chemical Biology of Presenilin Complexes.

  2017influential citation
• Discovery of cyclopropyl chromane-derived pyridopyrazine-1,6-dione γ-secretase modulators with robust central efficacy.

  2017cites this paper
• Targeting γ-Secretase for the Treatment of Alzheimer’s Disease

  2017cites this paper
• γ-Secretase Modulators as Aβ42-Lowering Pharmacological Agents to Treat Alzheimer’s Disease

  2017cites this paper
• Gamma Secretase Modulators: New Alzheimer's Drugs on the Horizon?

  2016cites this paper
• Quantitative Assessment of the Impact of Fluorine Substitution on P-Glycoprotein (P-gp) Mediated Efflux, Permeability, Lipophilicity, and Metabolic Stability.

  2016cites this paper
• Recent developments and applications of clickable photoprobes in medicinal chemistry and chemical biology.

  2015cites this paper
• Design of Pyridopyrazine-1,6-dione γ-Secretase Modulators that Align Potency, MDR Efflux Ratio, and Metabolic Stability.

  2015cites this paper
• Discovery of indole-derived pyridopyrazine-1,6-dione γ-secretase modulators that target presenilin.

  2015cites this paper
• Identification of a Potent Inhibitor of CREB-Mediated Gene Transcription with Efficacious in Vivo Anticancer Activity

  2015cites this paper
• Potent benzoazepinone γ-secretase modulators with improved bioavailability.

  2015cites this paper
• Chromène et 1,1a,2,7b-tétrahydrocyclopropa[c]chromène pyridopyrazinediones comme modulateurs de gamma-sécrétase

  2015cites this paper
• Anilinotriazoles as potent gamma secretase modulators.

  2014cites this paper
• 1,1′-Sulfinyldipyridinium bis (hydrogen sulfate) ionic liquid: synthesis and application in the temperature-influenced synthesis of novel pyranopyrimidinediones and pyranopyrimidinetriones

  2014cites this paper